The 35th Annual Meeting of the Japanese Society for Histocompatibility and Immunogenetics【Aichi Prefecture】

HLA and MHC / Immunogenetics / Histocompatibility Testing / Transplantation / Japan

Meeting Theme and Objectives

The Japanese Society for Histocompatibility and Immunogenetics was established in 1992, building on the Japanese histocompatibility research group founded in 1972. The society advances basic research, histocompatibility testing technologies, transplantation medicine and regenerative medicine through collaboration with domestic and international research institutions, dissemination of specialist knowledge and professional education.

Histocompatibility research encompasses HLA matching between donors and recipients, immune responses associated with transplantation, and immunological risk assessment. It brings together researchers and healthcare professionals to share advances in basic and clinical research and laboratory technologies supporting improved transplantation outcomes.

As of November 13, 2026, the official theme and meeting president’s message for the 35th annual meeting have not been confirmed.

Official information: JSHI Statutes and Objectives (Japanese)

35th Annual Meeting of the Japanese Society for Histocompatibility and Immunogenetics: Event Information

• Official Japanese Name: 第35回日本組織適合性学会大会
• English Name: The 35th Annual Meeting of the Japanese Society for Histocompatibility and Immunogenetics (English rendering based on the society’s official English name).
• Dates: September 24–26, 2027 (Friday–Sunday).
• Venue: Nagoya Congress Center.
• Address: 1-1 Atsutanishimachi, Atsuta-ku, Nagoya, Aichi 456-0036, Japan.
• Organizer: Japanese Society for Histocompatibility and Immunogenetics (JSHI).
• Meeting Format: A physical venue has been announced. Online streaming and hybrid participation arrangements have not been confirmed.
• Dedicated Meeting Website: Listed as not yet published on the official society meeting schedule.

Official information: JSHI Annual Meeting Information (Japanese)

Meeting Organization

Meeting President: Dr. Satoko Morishima (Chubu Cord Blood Bank)

Dr. Morishima serves on the JSHI board of directors and is listed as the president of the 35th annual meeting in the society’s official meeting schedule. Chubu Cord Blood Bank supports activities related to hematopoietic stem cell transplantation using cord blood. The meeting is therefore also of interest to researchers working at the intersection of histocompatibility research and hematopoietic cell transplantation.

• Meeting President: Dr. Satoko Morishima.
• Affiliation: Chubu Cord Blood Bank.
• Organizing Committee and Vice President: Under preparation.
• Dedicated Meeting Secretariat and Administrative Secretariat: Details not confirmed.
• Inquiries: Consult the contact information on the official JSHI website.

Official information: Meeting President and Schedule (Japanese) / JSHI Board of Directors (Japanese)

Key Research Areas and Highlights

The following are representative research areas relevant to the scientific activities and specialist disciplines of JSHI. They do not constitute a confirmed list of presentations or sessions at the 35th annual meeting.

• HLA, MHC and Immunogenetics: HLA gene polymorphism, antigen presentation, T cell and natural killer (NK) cell responses, and associations between HLA and disease.
• HLA Typing and Molecular Genetics: DNA-based HLA typing, PCR-based analysis and high-resolution typing using next-generation sequencing (NGS).
• Anti-HLA Antibodies and Histocompatibility Testing: Antibody specificity assessment, donor-specific antibodies (DSA), crossmatch testing and pretransplant immunological risk assessment.
• Hematopoietic Stem Cell and Cord Blood Transplantation: HLA matching, donor selection, graft-versus-host disease (GVHD), immune reconstitution and graft-versus-leukemia (GVL) effects.
• Organ Transplantation and Transplant Immunology: Kidney and other organ transplantation, rejection, post-transplant immune monitoring and antibody-mediated rejection.
• Regenerative Medicine and Cell Therapy: Immunological compatibility in cell and tissue transplantation, immunogenicity of cell-based products, and the use of HLA information in cell banking.
• Laboratory Quality Management: Standardization of HLA testing, quality control of DNA and antibody assays, reproducibility of test results and external quality assessment.

Pharma Nexus highlights: Relevant technologies include HLA typing reagents, nucleic acid extraction systems, automated liquid handling, sequencing instruments, antibody testing systems, flow cytometers, cellular analysis, sample storage and cryopreservation, and cell culture systems. Improving HLA testing accuracy, applying genomic information to donor selection and increasing workflow efficiency in transplant immunology research are particularly noteworthy. These are related technology areas, not confirmed products to be exhibited at the 35th annual meeting.

Official information: JSHI HLA Resources (Japanese) / Histocompatibility Testing Quality Control Workshop (Japanese)

Call for Abstracts and Research Presentations

Details of general abstract submissions, including submission dates, eligibility requirements, submission procedures and abstract formatting instructions for the 35th annual meeting, have not been confirmed.

• Abstract Submission Opening Date: Under preparation.
• Abstract Submission Deadline: Under preparation.
• Eligibility and Abstract Requirements: Under preparation.
• Oral and Poster Presentations: Details not confirmed.
• Acceptance Notifications and Presenter Registration Requirements: Under preparation.

Researchers considering presentations on HLA and MHC research, transplant immunology, laboratory testing technologies or standardization of histocompatibility testing should consult the forthcoming official submission guidelines. Submission dates and requirements from the 34th annual meeting in 2026 have not been applied.

Official information: Annual Meeting and Abstract Submission Updates (Japanese)

Scientific Program and Schedule

The detailed scientific program, special lectures, symposia, general presentations, educational lectures and speakers for the 35th annual meeting are under preparation.

Reference: JSHI Educational and Quality Control Activities

• Certified HLA Testing Technologist Training: Educational activities supporting the acquisition and advancement of HLA testing techniques and specialist knowledge.
• HLA Quality Control Workshop (QCWS): Histocompatibility testing quality control activities covering DNA testing and antibody testing.
• Professional Certification: Certification programs for HLA testing technologists, HLA educators and histocompatibility specialists.

The 34th annual meeting published information on participation in HLA testing technologist training and QCWS sessions, including attendance certificates. However, the availability of corresponding activities at the 35th annual meeting, their schedules, accreditation credits and attendance requirements have not been confirmed.

Official information: Annual Meeting Information (Japanese) / HLA Quality Control Workshop (Japanese) / Professional Certification Regulations (Japanese)

Registration and Fees

Official registration dates, participation fees and rates for members, nonmembers and students at the 35th annual meeting have not been confirmed.

• Advance Registration: Under preparation.
• On-Site Registration: Details not confirmed.
• Registration Fees and Categories: Under preparation.
• Professional Certification Credits and Attendance Certificates: Details not confirmed.
• Online Participation and Accommodation: Details not confirmed.

Participants seeking professional certification credits or attendance certificates should consult the 2027 meeting registration requirements and JSHI’s official certification information. Fees and accreditation conditions from the previous annual meeting have not been applied.

Official information: Annual Meeting and Registration Information (Japanese)

Corporate Sponsorship and Exhibition Opportunities

Official sponsorship information for corporate exhibitions, co-sponsored seminars, advertising and donations at the 35th Annual Meeting of the Japanese Society for Histocompatibility and Immunogenetics has not been confirmed.

• Exhibitor and Sponsorship Applications: Under preparation.
• Exhibitor Application Deadline: Under preparation.
• Exhibition Fees and Booth Specifications: Under preparation.
• Co-Sponsored Seminars, Advertising and Sponsorship Packages: Details not confirmed.
• Exhibition Dates and Move-in/Move-out Schedule: Details not confirmed.

Relevant Industries: HLA testing reagents, molecular diagnostic instruments, anti-HLA antibody testing systems, flow cytometry, nucleic acid extraction and sequencing, cell culture, cryopreservation, laboratory automation and clinical laboratory data management.

For reference, the 34th annual meeting in 2026 published a sponsorship prospectus and received corporate support. Please consult forthcoming official announcements to confirm exhibition arrangements, sponsorship fees and application requirements for the 35th annual meeting. Exhibition fees and application deadlines from the previous meeting have not been applied.

Official information: 35th Annual Meeting Updates (Japanese)

Venue and Access

Nagoya Congress Center
1-1 Atsutanishimachi, Atsuta-ku, Nagoya, Aichi 456-0036, Japan

• Hibino Station, Subway Meiko Line: Approximately five minutes on foot.
• Nishi-Takakura Station, Subway Meijo Line: Approximately five minutes on foot.

Renovation and Temporary Closure: According to the official venue announcement, Nagoya Congress Center is temporarily closed in its entirety from February 1, 2025, through March 31, 2027. The dates of the 35th annual meeting, September 24–26, 2027, fall after the announced closure period. Please consult forthcoming official information regarding facility use after renovation, specific meeting rooms, exhibition areas and registration locations.

Official information: Nagoya Congress Center Access Guide (Japanese) / Official Temporary Closure Announcement (Japanese)

Official Websites

35th JSHI Annual Meeting Information (Japanese)

Japanese Society for Histocompatibility and Immunogenetics

Histocompatibility Testing Quality Control and HLA-QC Workshop (Japanese)

JSHI Certification and Regulations (Japanese)

Reference: 34th Annual Meeting Official Website (2026, Japanese)

Nagoya Congress Center Official Website

Information checked November 13, 2026. Meeting dates, venue and meeting president are based on the official JSHI future meeting schedule. A dedicated website for the 35th annual meeting has not yet been published. Please consult forthcoming official announcements for the meeting theme, abstract submission guidelines, detailed program, registration and corporate sponsorship requirements.